Drug profile · INN
methoxyflurane
PENTHROX (COMBINATION PACK)
methoxyflurane (PENTHROX (COMBINATION PACK)) is a gaba-a receptor; anion channel positive modulator. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — methoxyflurane
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
methoxyflurane (PENTHROX (COMBINATION PACK)) is a gaba-a receptor; anion channel positive modulator. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is methoxyflurane?
methoxyflurane (PENTHROX (COMBINATION PACK)) is a gaba-a receptor; anion channel positive modulator. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for methoxyflurane?
PENTHROX (COMBINATION PACK) is a marketed brand name for methoxyflurane. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methoxyflurane?
methoxyflurane has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.